Eli Lilly Weight-Loss Pill Prescriptions Near 1,400 in First Week [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
week on the U.S. market, it only got roughly 1,390 prescriptions.The number demonstrates how much demand there is, but it also shows how much work the company still has to do. Novo Nordisk is still the leader in the field, with its competing therapy getting more than 113,000 prescriptions during the same time period.That disparity isn't too surprising. Novo Nordisk has been around longer and has already built up a great reputation with doctors and a lot of demand from patients. On the other hand, Lilly is just now starting to sell its medication after getting the green light.On April 1, the business got permission from the U.S. government to sell the once-daily medication to individuals who are overweight or have weight-related problems. It rapidly made the medicine available through its direct-to-consumer platform in order to speed up uptake.For now, the early numbers are more about getting a foothold than about competing right away. The real test will be whether prescriptions start
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Novo GLP-1 drug shows less lean mass loss than rivals, study says [USA TODAY]USA TODAY
- Novo Nordisk's Wegovy Wins EMA Flexibility In GLP-1 Access Push [Yahoo! Finance]Yahoo! Finance
- Novo obesity drug outperforms Lilly's in preserving lean body mass: study [Seeking Alpha]Seeking Alpha
- Kailera makes history with record-breaking $625m IPO [Yahoo! Finance]Yahoo! Finance
- Lilly's Foundayo hits 1,390 prescriptions in debut week [Yahoo! Finance Canada]Yahoo! Finance Canada
NVO
Earnings
- 2/3/26 - Beat
NVO
Sec Filings
- 4/13/26 - Form 6-K
- 4/7/26 - Form 6-K
- 3/30/26 - Form 6-K
- NVO's page on the SEC website